30-Oct-2024	Application for quotation of securities - COH

30-Oct-2024	Application for quotation of securities - COH

25-Oct-2024	2024 AGM Results

15-Oct-2024	Notification of cessation of securities - COH

11-Oct-2024	Update - Notification of buy-back - COH

10-Oct-2024	Notification of cessation of securities - COH

10-Oct-2024	Notification regarding unquoted securities - COH

10-Oct-2024	Notification regarding unquoted securities - COH

10-Oct-2024	Update - Notification of buy-back - COH

9-Oct-2024	Update - Notification of buy-back - COH

7-Oct-2024	Update - Notification of buy-back - COH

4-Oct-2024	Update - Notification of buy-back - COH

3-Oct-2024	Update - Notification of buy-back - COH

30-Sep-2024	Update - Notification of buy-back - COH

26-Sep-2024	Appendix 3Y - Diggory Howitt

26-Sep-2024	Notification regarding unquoted securities - COH

26-Sep-2024	Update - Notification of buy-back - COH

24-Sep-2024	Update - Notification of buy-back - COH

23-Sep-2024	Update - Dividend/Distribution - COH

20-Sep-2024	Update - Notification of buy-back - COH

19-Sep-2024	Cochlear announces Chief Financial Officer appointment

19-Sep-2024	Update - Notification of buy-back - COH

18-Sep-2024	COH Notice of Annual General Meeting & Proxy/Voting Form

18-Sep-2024	Update - Notification of buy-back - COH

17-Sep-2024	Appendix 3Y - Diggory Howitt

17-Sep-2024	Notification regarding unquoted securities - COH

17-Sep-2024	Update - Notification of buy-back - COH

3-Sep-2024	Appendix 3X - Caroline Clarke

30-Aug-2024	Notification regarding unquoted securities - COH

30-Aug-2024	Appendix 3Y - Karen Penrose

28-Aug-2024	Appendix 3Y - Michael del Prado

27-Aug-2024	Becoming a substantial holder

27-Aug-2024	Amended notice of ceasing to be a substantial holder

26-Aug-2024	Notice of ceasing to be a substantial holder

23-Aug-2024	Becoming a substantial holder

23-Aug-2024	Appendix 3Y - Christine McLoughlin

23-Aug-2024	Appendix 3Y - Karen Penrose

22-Aug-2024	Appendix 3Y - Diggory Howitt

21-Aug-2024	Notification of cessation of securities - COH

20-Aug-2024	Notification regarding unquoted securities - COH

15-Aug-2024	Notification of buy-back - COH

15-Aug-2024	Appendix 4G

15-Aug-2024	Application for quotation of securities - COH

15-Aug-2024	Date of AGM and closing date for director nominations

15-Aug-2024	2024 Tax Contribution Report

15-Aug-2024	FY24 Result - Presentation

15-Aug-2024	FY24 Result - ASX & Media Release

15-Aug-2024	Dividend/Distribution - COH

15-Aug-2024	Appendix 4E

15-Aug-2024	Annual Report (incl Sustainability reporting)

30-Jul-2024	Appointment of Caroline Clarke to the Cochlear Board

26-Jul-2024	Cochlear announces changes to the executive team

25-Jul-2024	Application for quotation of securities - COH

10-Jul-2024	COH Notice of FY24 result analyst and media briefing

5-Jul-2024	Notification of cessation of securities - COH

5-Jul-2024	Notification regarding unquoted securities - COH

5-Jul-2024	Notification regarding unquoted securities - COH

23-May-2024	Change of registry address

21-May-2024	Cochlear acquires Demant cochlear implant business

20-May-2024	Change in substantial holding

30-Apr-2024	Application for quotation of securities - COH

22-Apr-2024	Appointments and retirement of Company Secretary

5-Apr-2024	Notification of cessation of securities - COH

4-Apr-2024	AXX: ACCC will not oppose revised Cochlear, Oticon transacti

2-Apr-2024	Appendix 3Z - Yasmin Allen

2-Apr-2024	Update - Dividend/Distribution - COH

25-Mar-2024	Resignation of Director - Yasmin Allen

15-Mar-2024	Appendix 3Y - Diggory Howitt

15-Mar-2024	Notification regarding unquoted securities - COH

28-Feb-2024	Notification regarding unquoted securities - COH

22-Feb-2024	Notification regarding unquoted securities - COH

19-Feb-2024	HY24 Result - Presentation Slides

19-Feb-2024	Update - Notification of buy-back - COH

19-Feb-2024	Appendix 4D and Half Year Financial Report

19-Feb-2024	Dividend/Distribution - COH

19-Feb-2024	HY24 Result - ASX & Media Release

8-Feb-2024	Cochlear Upgrades FY24 Earnings Guidance

8-Feb-2024	Cochlear Upgrades FY24 Earnings Guidance

12-Jan-2024	Notification of cessation of securities - COH

10-Jan-2024	Notification regarding unquoted securities - COH

8-Jan-2024	Notice of HY24 result analyst and media briefing

19-Dec-2023	Notification of cessation of securities - COH

7-Dec-2023	Notification regarding unquoted securities - COH

7-Dec-2023	Update - Notification of buy-back - COH

6-Dec-2023	Update - Notification of buy-back - COH

30-Nov-2023	Update - Notification of buy-back - COH

24-Nov-2023	Notification of cessation of securities - COH

23-Nov-2023	Update - Notification of buy-back - COH

16-Nov-2023	Appendix 3Y - Michael del Prado

10-Nov-2023	Update - Notification of buy-back - COH

9-Nov-2023	Update - Notification of buy-back - COH

8-Nov-2023	Ceasing to be a substantial holder

7-Nov-2023	Notification regarding unquoted securities - COH

3-Nov-2023	Notification of cessation of securities - COH

1-Nov-2023	Notification regarding unquoted securities - COH

1-Nov-2023	Update - Notification of buy-back - COH

31-Oct-2023	Update - Notification of buy-back - COH

30-Oct-2023	Application for quotation of securities - COH

27-Oct-2023	Cochlear Capital Markets Day Presentation

25-Oct-2023	Application for quotation of securities - COH

25-Oct-2023	Notification regarding unquoted securities - COH

23-Oct-2023	Appendix 3Y - Karen Penrose

23-Oct-2023	Appendix 3Y - Diggory Howitt

23-Oct-2023	Notification regarding unquoted securities - COH

19-Oct-2023	Notification regarding unquoted securities - COH

19-Oct-2023	Appendix 3Z - Andrew Denver

17-Oct-2023	2023 AGM Results

16-Oct-2023	Notification of cessation of securities - COH

12-Oct-2023	Notification of cessation of securities - COH

11-Oct-2023	Late Lodgement of Appendix 3H

11-Oct-2023	Notification of cessation of securities - COH

3-Oct-2023	Becoming a substantial holder

2-Oct-2023	Update - Notification of buy-back - COH

29-Sep-2023	Update - Notification of buy-back - COH

28-Sep-2023	Update - Notification of buy-back - COH

27-Sep-2023	Correction to Notice of Annual General Meeting

27-Sep-2023	Update - Notification of buy-back - COH

26-Sep-2023	Update - Dividend/Distribution - COH

26-Sep-2023	Update - Notification of buy-back - COH

25-Sep-2023	Update - Notification of buy-back - COH

22-Sep-2023	Notification of cessation of securities - COH

22-Sep-2023	Update - Notification of buy-back - COH

21-Sep-2023	Update - Notification of buy-back - COH

20-Sep-2023	Update - Notification of buy-back - COH

19-Sep-2023	Update - Notification of buy-back - COH

18-Sep-2023	Appendix 3Y - Diggory Howitt

18-Sep-2023	Notification regarding unquoted securities - COH

15-Sep-2023	COH Notice of Annual General Meeting and Voting Form

8-Sep-2023	Notification of cessation of securities - COH

7-Sep-2023	Update - Notification of buy-back - COH

6-Sep-2023	Notification regarding unquoted securities - COH

6-Sep-2023	Appendix 3Y - Karen Penrose

6-Sep-2023	Update - Notification of buy-back - COH

5-Sep-2023	Appendix 3Y - Christine Frances McLoughlin

5-Sep-2023	Update - Notification of buy-back - COH

1-Sep-2023	Notification regarding unquoted securities - COH

1-Sep-2023	Update - Notification of buy-back - COH

31-Aug-2023	Notification regarding unquoted securities - COH

30-Aug-2023	Notification regarding unquoted securities - COH

30-Aug-2023	Update - Notification of buy-back - COH

29-Aug-2023	Appendix 3Y - Diggory Howitt

29-Aug-2023	Notification regarding unquoted securities - COH

29-Aug-2023	Cochlear Capital Markets Day

28-Aug-2023	Notification regarding unquoted securities - COH

28-Aug-2023	Update - Notification of buy-back - COH

22-Aug-2023	Appendix 3Y - Michael del Prado

22-Aug-2023	Appendix 3Y - Michael Daniell

22-Aug-2023	Appendix 3Y - Diggory Howitt

22-Aug-2023	Notification of cessation of securities - COH

17-Aug-2023	Notification regarding unquoted securities - COH

15-Aug-2023	Appendix 4G

15-Aug-2023	2023 Corporate Governance Statement

15-Aug-2023	2023 Tax Contribution Report

15-Aug-2023	FY23 Result - Presentation

15-Aug-2023	FY23 Result - ASX & Media Release

15-Aug-2023	Dividend/Distribution - COH

15-Aug-2023	Annual Report (incl Sustainability reporting)

15-Aug-2023	Appendix 4E

14-Aug-2023	Application for quotation of securities - COH

31-Jul-2023	Application for quotation of securities - COH

28-Jul-2023	Late Lodgement of Appendix 3H

28-Jul-2023	Notification of cessation of securities - COH

18-Jul-2023	Retirement of Director - Andrew Denver

10-Jul-2023	COH Notice of FY23 result analyst and media briefing

7-Jul-2023	Notification of cessation of securities - COH

3-Jul-2023	Financial Calendar Key Dates FY24

3-Jul-2023	Update - Notification of buy-back - COH

30-Jun-2023	Update - Notification of buy-back - COH

29-Jun-2023	Update - Notification of buy-back - COH

28-Jun-2023	Update - Notification of buy-back - COH

23-Jun-2023	Update - Notification of cessation of securities - COH

23-Jun-2023	Update - Notification of cessation of securities - COH

22-Jun-2023	Oticon Medical Acquisition - UK CMA Final Report & Update

22-Jun-2023	Update - Notification of buy-back - COH

14-Jun-2023	Update - Notification of buy-back - COH

13-Jun-2023	Update - Notification of buy-back - COH

9-Jun-2023	Becoming a substantial holder

9-Jun-2023	Notification of cessation of securities - COH

9-Jun-2023	Update - Notification of buy-back - COH

7-Jun-2023	Update - Notification of buy-back - COH

6-Jun-2023	Update - Notification of buy-back - COH

5-Jun-2023	Update - Notification of buy-back - COH

1-Jun-2023	Update - Notification of buy-back - COH

30-May-2023	Update - Notification of buy-back - COH

26-May-2023	Update - Notification of buy-back - COH

25-May-2023	Update - Notification of buy-back - COH

24-May-2023	Update - Notification of buy-back - COH

22-May-2023	Update - Notification of buy-back - COH

19-May-2023	Notification of cessation of securities - COH

19-May-2023	Update - Notification of buy-back - COH

18-May-2023	Update - Notification of buy-back - COH

17-May-2023	Update - Notification of buy-back - COH

12-May-2023	Update - Notification of buy-back - COH

27-Apr-2023	Application for quotation of securities - COH

20-Apr-2023	Provisional findings from the UK CMA

20-Apr-2023	Update - Notification of buy-back - COH

19-Apr-2023	Update - Notification of buy-back - COH

18-Apr-2023	Notification regarding unquoted securities - COH

18-Apr-2023	Notification of cessation of securities - COH

18-Apr-2023	Update - Notification of buy-back - COH

17-Apr-2023	Update - Notification of buy-back - COH

14-Apr-2023	Update - Notification of buy-back - COH

6-Apr-2023	Update - Notification of buy-back - COH

4-Apr-2023	Update - Notification of buy-back - COH

3-Apr-2023	Update - Dividend/Distribution - COH

3-Apr-2023	Update - Notification of buy-back - COH

30-Mar-2023	Update - Notification of buy-back - COH

29-Mar-2023	Update - Notification of buy-back - COH

28-Mar-2023	Update - Notification of buy-back - COH

24-Mar-2023	Update - Notification of buy-back - COH

23-Mar-2023	Update - Notification of buy-back - COH

20-Mar-2023	Update - Notification of buy-back - COH

17-Mar-2023	Update - Notification of buy-back - COH

16-Mar-2023	Update - Notification of buy-back - COH

15-Mar-2023	Update - Notification of buy-back - COH

9-Mar-2023	Update - Notification of buy-back - COH

6-Mar-2023	Appendix 3Y - Michael del Prado

2-Mar-2023	Update - Notification of buy-back - COH

17-Feb-2023	Cochlear Limited - Revised Trading Policy

15-Feb-2023	Update - Dividend/Distribution - COH

15-Feb-2023	Notification of buy-back - COH

15-Feb-2023	HY23 Result - Presentation Slides

15-Feb-2023	HY23 Result - ASX & Media Release

15-Feb-2023	Dividend/Distribution - COH

15-Feb-2023	Appendix 4D and Half Year Financial Report

30-Jan-2023	Application for quotation of securities - COH

24-Jan-2023	Notice of HY23 result analyst and media briefing

12-Jan-2023	Notification of cessation of securities - COH

7-Dec-2022	Oticon Medical acquisition - UK CMA decision

1-Dec-2022	Acquisition of Oticon Medical-ACCC Statement

1-Dec-2022	AXX: Preliminary concerns Cochlear Oticon proposed acquisiti

3-Nov-2022	Notification regarding unquoted securities - COH

2-Nov-2022	Appendix 3Y - Michael del Prado

31-Oct-2022	Appendix 3Y - Alison Deans

28-Oct-2022	Appendix 3Y - Bruce Robinson

26-Oct-2022	Application for quotation of securities - COH

24-Oct-2022	Appendix 3Y - Karen Penrose

24-Oct-2022	Application for quotation of securities - COH

20-Oct-2022	Appendix 3Y - Diggory Howitt

20-Oct-2022	Notification regarding unquoted securities - COH

18-Oct-2022	2022 AGM Results

18-Oct-2022	2022 AGM Chair and CEO & President Addresses

12-Oct-2022	Notification of cessation of securities - COH

6-Oct-2022	Appendix 3Y - Diggory Howitt

6-Oct-2022	Notification regarding unquoted securities - COH

4-Oct-2022	Update - Dividend/Distribution - COH

23-Sep-2022	Notification regarding unquoted securities - COH

16-Sep-2022	COH Notice of Annual General Meeting and Voting Form

16-Sep-2022	Update - Dividend/Distribution - COH

9-Sep-2022	Appendix 3Y - Karen Penrose

2-Sep-2022	Appendix 3Y - Michael del Prado

31-Aug-2022	Appendix 3Y - Michael del Prado

26-Aug-2022	Appendix 3Y - Karen Penrose

26-Aug-2022	Appendix 3Y - Christine Frances McLoughlin

25-Aug-2022	Appendix 3Y - Michael Daniell

24-Aug-2022	Notification of cessation of securities - COH

19-Aug-2022	Application for quotation of securities - COH

19-Aug-2022	Appendix 4G

19-Aug-2022	2022 Corporate Governance Statement

19-Aug-2022	2022 Tax Contribution Report

19-Aug-2022	2022 Sustainability Report

19-Aug-2022	FY22 Result Presentation

19-Aug-2022	FY22 Result - ASX & Media Release

19-Aug-2022	Dividend/Distribution - COH

19-Aug-2022	2022 Annual Report

19-Aug-2022	Appendix 4E

9-Aug-2022	Date of AGM and closing date for director nominations

29-Jul-2022	Application for quotation of securities - COH

25-Jul-2022	COH Notice of FY22 result analyst and media briefing

13-Jul-2022	Notification of cessation of securities - COH

1-Jul-2022	Appendix 3X - Karen Penrose

17-Jun-2022	Ceasing to be a substantial holder

27-May-2022	Appointment to Cochlear Board - Karen Penrose

5-May-2022	Application for quotation of securities - COH

27-Apr-2022	Cochlear agrees to acquire Oticon Medical

12-Apr-2022	Notification of cessation of securities - COH

7-Apr-2022	Change in substantial holding

29-Mar-2022	Notification of cessation of securities - COH

22-Feb-2022	Half Year Results Presentation

22-Feb-2022	Half Year Results Announcement

22-Feb-2022	Dividend/Distribution - COH

22-Feb-2022	Appendix 4D and Half Year Financial Report

1-Feb-2022	Application for quotation of securities - COH

13-Jan-2022	Notification of cessation of securities - COH

11-Jan-2022	Notice of HY22 result analyst and media briefing

5-Jan-2022	Appendix 3X - Michael del Prado

17-Dec-2021	Appointment of Michael del Prado to Cochlear Board

8-Dec-2021	Change in leadership for Cochlear North America

15-Nov-2021	Becoming a substantial holder

11-Nov-2021	Jobkeeper Payments Notification

3-Nov-2021	Ceasing to be a substantial holder

29-Oct-2021	Appendix 3Y - Christine Frances McLoughlin

29-Oct-2021	Notification regarding unquoted securities - COH

26-Oct-2021	Notification regarding unquoted securities - COH

22-Oct-2021	Appendix 3Y - Diggory Howitt

22-Oct-2021	Becoming a substantial holder

21-Oct-2021	Notification regarding unquoted securities - COH

19-Oct-2021	Results of Meeting

19-Oct-2021	2021 Cochlear AGM Presentation to Shareholders

14-Oct-2021	Notification of cessation of securities - COH

8-Oct-2021	Application for quotation of securities - COH

6-Oct-2021	Appendix 3Y - Diggory Howitt

6-Oct-2021	Notification regarding unquoted securities - COH

24-Sep-2021	Cochlear advises of US patent infringement complaint

23-Sep-2021	Notification regarding unquoted securities - COH

16-Sep-2021	COH Notice of Annual General Meeting and Proxy/Voting Form

14-Sep-2021	Notification regarding unquoted securities - COH

9-Sep-2021	Appendix 3Y - Diggory Howitt

7-Sep-2021	Notification regarding unquoted securities - COH

2-Sep-2021	Notification regarding unquoted securities - COH

27-Aug-2021	Notification of cessation of securities - COH

27-Aug-2021	Appendix 3Y - Christine Frances McLoughlin

26-Aug-2021	Notification regarding unquoted securities - COH

25-Aug-2021	Appendix 3Y - Diggory Howitt

24-Aug-2021	Notification regarding unquoted securities - COH

23-Aug-2021	Appendix 3Z - Rick Holliday-Smith

20-Aug-2021	Application for quotation of securities - COH

20-Aug-2021	Appendix 4G

20-Aug-2021	2021 Corporate Governance Statement

20-Aug-2021	2021 Tax Contribution Report

20-Aug-2021	2021 Sustainability Report

20-Aug-2021	FY21 Result Presentation

20-Aug-2021	FY21 Result - ASX & Media Release

20-Aug-2021	Dividend/Distribution - COH

20-Aug-2021	2021 Annual Report

20-Aug-2021	Appendix 4E

10-Aug-2021	Date of AGM and closing date for director nominations

23-Jul-2021	Appendix 3Z - Abbas Hussain

22-Jul-2021	COH Notice of FY21 result analyst and media briefing

20-Jul-2021	Resignation of Director - Abbas Hussain

13-Jul-2021	Notification of cessation of securities - COH

30-Jun-2021	Becoming a substantial holder

30-Jun-2021	Ceasing to be a substantial holder

24-Jun-2021	Becoming a substantial holder

7-Jun-2021	Change in substantial holding

31-May-2021	Becoming a substantial holder

31-May-2021	Cochlear announces new Chair

20-May-2021	Change in substantial holding

17-May-2021	Becoming a substantial holder

3-May-2021	Change in substantial holding

27-Apr-2021	Change in substantial holding

11-Mar-2021	Appendix 2A

1-Mar-2021	Appendix 3Y - Alison Deans

24-Feb-2021	COH receives FDA approval for Baha 6 Max Sound Processor

19-Feb-2021	HY21 Result Presentation Slides

19-Feb-2021	COH HY21 Result ASX & Media Release

19-Feb-2021	Dividend/Distribution - COH

19-Feb-2021	Half Yearly Report and Accounts

12-Feb-2021	Appointment of Stu Sayers as CFO

9-Feb-2021	Appendix 2A

21-Jan-2021	Notice of HY21 result analyst and media briefing

15-Dec-2020	Stu Sayers appointed Acting CFO

15-Dec-2020	Denial of Appeal in US patent infringement case

13-Nov-2020	Typographical Errors in the Constitution of Cochlear

11-Nov-2020	Appendix 2A

2-Nov-2020	Appendix 3X - Christine Frances McLoughlin

29-Oct-2020	Appendix 2A

23-Oct-2020	Appendix 3G

22-Oct-2020	Appendix 3Z - Donal O'Dwyer

22-Oct-2020	Appendix 3G

22-Oct-2020	Appendix 3Y - Diggory Howitt

21-Oct-2020	Appendix 2A

20-Oct-2020	New Constitution of Cochlear Limited

20-Oct-2020	Results of Meeting

20-Oct-2020	2020 Cochlear AGM Presentation to Shareholders

20-Oct-2020	First quarter trading update

25-Sep-2020	Appendix 3G

21-Sep-2020	Appendix 2A

18-Sep-2020	COH Notice of Annual General Meeting and Proxy/Voting Form

9-Sep-2020	Appendix 3Y - Bruce Robinson

1-Sep-2020	Appendix 3Y - Bruce Robinson

28-Aug-2020	Publication of global consensus paper

28-Aug-2020	Appendix 3Y - Abbas Hussain

27-Aug-2020	Change in substantial holding

26-Aug-2020	Appendix 2A

26-Aug-2020	Appendix 3Y - Diggory Howitt

24-Aug-2020	Appendix 2A

24-Aug-2020	Appendix 2A

24-Aug-2020	Appendix 2A

21-Aug-2020	Appendix 2A

20-Aug-2020	Corrections to 2020 Annual Report

20-Aug-2020	Appendix 2A

20-Aug-2020	Appendix 3Y - Diggory Howitt

18-Aug-2020	Appendix 2A

18-Aug-2020	AGM date & Director nominations

18-Aug-2020	2020 Tax Contribution Report

18-Aug-2020	Appendix 4G

18-Aug-2020	2020 ESG Report

18-Aug-2020	2020 Corporate Governance Statement

18-Aug-2020	2020 Annual Report

18-Aug-2020	2020 Strategy Overview

18-Aug-2020	FY20 Result Presentation Slides

18-Aug-2020	FY20 result - ASX & media release

18-Aug-2020	Appendix 4E

17-Aug-2020	Appointment to Cochlear Board - Christine McLoughlin

17-Aug-2020	Intention to Retire from Cochlear Board - Donal O'Dwyer

17-Aug-2020	Settlement in US Patent Infringement Case

7-Aug-2020	COH Notice of FY20 result analyst and media briefing

27-Jul-2020	Cochlear Limited - Revised Trading Policy

13-Jul-2020	Resignation of CFO

3-Jul-2020	Cochlear advises of FDA approval for four new products

29-Jun-2020	Appendix 3Y - Bruce Robinson

19-May-2020	Denial of appeal rehearing in US patent infringement case

11-May-2020	Confirmation of COVID-19 pandemic impact on trading

6-May-2020	Appendix 3Y - Donal O'Dwyer

6-May-2020	Appendix 3Y - Andrew Denver

5-May-2020	Appendix 3Y - Bruce Robinson

5-May-2020	Appendix 3Y - Yasmin Allen

4-May-2020	Appendix 3Y - Abbas Hussain

4-May-2020	Appendix 3Y - Rick Holliday-Smith

4-May-2020	Appendix 3Y - Michael Daniell

4-May-2020	Appendix 3Y - Glen Boreham

4-May-2020	Appendix 3Y - Diggory Howitt

4-May-2020	Appendix 3Y - Alison Deans

1-May-2020	Change in substantial holding

30-Apr-2020	Appendix 2A

28-Apr-2020	Cochlear Completes Share Purchase Plan

8-Apr-2020	Cochlear receives expedited FDA approval of Remote Check

7-Apr-2020	Temporary pay reduction for Board, CEO & senior executives

2-Apr-2020	Becoming a substantial holder

1-Apr-2020	Cochlear Share Purchase Plan Offer Open

30-Mar-2020	Appendix 2A

27-Mar-2020	Appendix 3B - Update to Proposed Issue of Securities - COH

17-Mar-2020	Adverse appeal decision in the US patent infringement case

16-Mar-2020	Cochlear withdraws FY20 earnings guidance due to coronavirus

12-Mar-2020	Appendix 2A

18-Feb-2020	HY20 Result Presentation Slides

18-Feb-2020	HY20 Result ASX & Media Release

18-Feb-2020	Dividend/Distribution - COH

18-Feb-2020	Half Yearly Report and Accounts

13-Feb-2020	Cochlear announces additional investment in Nyxoah

11-Feb-2020	Cochlear reduces earnings guidance due to coronavirus

6-Jan-2020	Initial Director's Interest Notice - Appendix 3X M G Daniell

11-Dec-2019	Change in substantial holding

10-Dec-2019	Appointment of Michael Daniell to the Cochlear Limited Board

21-Nov-2019	Appendix 3B

18-Nov-2019	FDA Clearance for Cochlear Osia 2 System

8-Nov-2019	Appendix 3B

4-Nov-2019	Appendix 3B

1-Nov-2019	Appendix 3B

28-Oct-2019	Appendix 3Y - Diggory Howitt

25-Oct-2019	Appendix 3B

25-Oct-2019	Appendix 3B

24-Oct-2019	Appendix 3B

22-Oct-2019	Correction - 2019 AGM Presentations to Shareholders

22-Oct-2019	COH 2019 AGM - Results of Meeting

22-Oct-2019	2019 Cochlear AGM Presentation to Shareholders

22-Oct-2019	2019 Chairman's AGM Address to Shareholders

22-Oct-2019	Change in substantial holding

15-Oct-2019	Appendix 3B

30-Sep-2019	Appendix 3B

30-Sep-2019	Appendix 3B

20-Sep-2019	Appendix 3Y - Diggory Howitt

17-Sep-2019	Appendix 3B

17-Sep-2019	COH Notice of Annual General Meeting

17-Sep-2019	COH Chairmans Letter and Proxy/Voting Form

16-Sep-2019	Ceasing to be a substantial holder

6-Sep-2019	Appendix 3B

4-Sep-2019	Ceasing to be a substantial holder

3-Sep-2019	Appendix 3B

30-Aug-2019	Appendix 3Y - Diggory Howitt

30-Aug-2019	Appendix 3B

28-Aug-2019	Appendix 3B

27-Aug-2019	Appendix 3Y - Abbas Hussain

23-Aug-2019	Appendix 3B

23-Aug-2019	Appendix 3Y - Diggory Howitt

22-Aug-2019	Appendix 3B

21-Aug-2019	Appendix 3B

16-Aug-2019	Appendix 3B

16-Aug-2019	Appendix 4G

16-Aug-2019	2019 Tax Contribution Report

16-Aug-2019	2019 ESG Report

16-Aug-2019	2019 Corporate Governance Statement

16-Aug-2019	2019 Annual Report

16-Aug-2019	2019 Strategy Overview

16-Aug-2019	FY19 Result Presentation Slides

16-Aug-2019	FY19 Results ASX & Media Release

16-Aug-2019	Dividend/Distribution - COH

16-Aug-2019	Appendix 4E

29-Jul-2019	Becoming a substantial holder

16-Jul-2019	Ceasing to be a substantial holder - amended

15-Jul-2019	Ceasing to be a substantial holder

17-Jun-2019	COH - Profile Plus FDA Approval

10-May-2019	COH Hosts Capital Markets Day 10 May 2019

16-Apr-2019	Cochlear announces launch of Nucleus Profile Plus implant

8-Mar-2019	UK cochlear implant criteria change

5-Mar-2019	Becoming a substantial holder from PNI

4-Mar-2019	Becoming a substantial holder

4-Mar-2019	Change of Director's Interest Notice

19-Feb-2019	COH Half Year Results Analyst - 19.02.2019

19-Feb-2019	COH Half Year Results Media Release - 19.02.2019

19-Feb-2019	Dividend/Distribution - COH

19-Feb-2019	Half Yearly Report and Accounts

11-Jan-2019	Appendix 3B

27-Nov-2018	Becoming a substantial holder

22-Nov-2018	Initial Director's Interest Notice - Appendix 3X S A Hussain

22-Nov-2018	Ceasing to be a substantial holder

21-Nov-2018	Becoming a substantial holder

20-Nov-2018	Appointment of Abbas Hussain to Cochlear Limited Board

14-Nov-2018	Appendix 3Y - Diggory Howitt

13-Nov-2018	COH Invest in Nyxoah

12-Nov-2018	Appendix 3B

12-Nov-2018	Appendix 3Y - Diggory Howitt

8-Nov-2018	Cochlear & GN Hearing Strengthen Tech & Commercial Alliance

6-Nov-2018	Appendix 3B

5-Nov-2018	COH - Ruling in USA Patent Infringement Case

31-Oct-2018	Appendix 3Y - Diggory Howitt

31-Oct-2018	Appendix 3Y - Bruce Robinson

24-Oct-2018	Appendix 3B

23-Oct-2018	Appendix 3Y - Bruce Robinson

19-Oct-2018	Appendix 3Z - Prof Edward Byrne

19-Oct-2018	Appendix 3B

16-Oct-2018	COH 2018 AGM - Results of Meeting

16-Oct-2018	2018 Cochlear AGM Presentation to Shareholders

16-Oct-2018	2018 Chairman's AGM Address to Shareholders

11-Oct-2018	Appendix 3B

11-Oct-2018	Appendix 3B

10-Oct-2018	Next phase development - totally implantable cochlear device

24-Sep-2018	Appendix 3B

12-Sep-2018	COH Chairman's Letter and Proxy/Voting Form

12-Sep-2018	COH Notice of Annual General Meeting

3-Sep-2018	Appendix 3B

3-Sep-2018	Appendix 3B

30-Aug-2018	Appendix 3Y - Diggory Howitt

28-Aug-2018	Appendix 3B

28-Aug-2018	Appendix 3Y - Diggory Howitt

24-Aug-2018	Appendix 3B

22-Aug-2018	Appendix 3Y - Diggory Howitt

21-Aug-2018	Appendix 3B

20-Aug-2018	Appendix 3Y - Bruce Robinson

15-Aug-2018	Appendix 3B

14-Aug-2018	Appendix 3B

14-Aug-2018	Appendix 4G

14-Aug-2018	COH 2018 Tax Contribution Report

14-Aug-2018	COH 2018 Corporate Governance Statement

14-Aug-2018	COH Investor Handbook - Aug 18

14-Aug-2018	COH 2018 Annual Report to shareholders

14-Aug-2018	COH FY18 Result Presentation Slides

14-Aug-2018	COH FY18 Result Announcement

14-Aug-2018	Dividend/Distribution - COH

14-Aug-2018	Full Year Statutory Accounts - COH Appendix 4E

13-Aug-2018	Director Appointment/Resignation

22-Jun-2018	COH announces release of Nucleus Smart App for Android

8-Jun-2018	S&P DJI Announces June Quarterly Rebalance

4-May-2018	COH Hosts Investor Day 4 May 2018

3-Apr-2018	Ceasing to be a substantial holder

28-Mar-2018	Becoming a substantial holder

26-Mar-2018	Amended Notice - Becoming a substantial holder

13-Mar-2018	Becoming a substantial holder

7-Mar-2018	Appendix 3Y - Dig Howitt

22-Feb-2018	Appendix 3B

13-Feb-2018	Ceasing to be a substantial holder

13-Feb-2018	Ceasing to be a substantial holder

13-Feb-2018	COH Half Year Results Analyst Presentation

13-Feb-2018	COH Half Year Results Media Release 13.02.2018

13-Feb-2018	Dividend/Distribution - COH

13-Feb-2018	Half Year Accounts

5-Feb-2018	Response to ASX query on Appendix 3Y

8-Jan-2018	Appendix 3Z - Chris Smith

22-Dec-2017	Change in substantial holding

13-Dec-2017	Appendix 3Y - Chris Smith

16-Nov-2017	Initial Director's Interest Notice

14-Nov-2017	COH CEO Transition and Related Board Changes

20-Oct-2017	Appendix 3B

20-Oct-2017	Appendix 3B

17-Oct-2017	COH 2017 AGM - Results of Meeting

17-Oct-2017	2017 Chairman's AGM Address to Shareholders

17-Oct-2017	2017 Cochlear AGM Presentation to Shareholders

9-Oct-2017	Appendix 3B

27-Sep-2017	Appendix 3B

25-Sep-2017	Appendix 3B

14-Sep-2017	Appendix 3Y - Alison Deans

14-Sep-2017	Appendix 3B

13-Sep-2017	AGM Proxy Form

13-Sep-2017	Notice of Annual General Meeting

11-Sep-2017	Appendix 3Y - Bruce Robinson

1-Sep-2017	Appendix 3B

30-Aug-2017	Appendix 3Y - Chris Smith

30-Aug-2017	Appendix 3B

29-Aug-2017	Appendix 3B

29-Aug-2017	Appendix 3B

28-Aug-2017	Appendix 3B

25-Aug-2017	Corrected - Appendix 3Y - Chris Smith

25-Aug-2017	Appendix 3Y - Chris Smith

22-Aug-2017	Appendix 3B

18-Aug-2017	Appendix 3Y - Chris Smith

18-Aug-2017	Appendix 3B

18-Aug-2017	Appendix 3B

17-Aug-2017	Appendix 3B

17-Aug-2017	Appendix 4G

17-Aug-2017	COH 2017 Tax Contribution Report

17-Aug-2017	COH 2017 Corporate Governance Statement

17-Aug-2017	COH Investor Handbook Aug17

17-Aug-2017	COH 2017 Annual Report

17-Aug-2017	COH FY17 Result Presentation Slides

17-Aug-2017	COH FY17 Result Announcement

17-Aug-2017	Dividend/Distribution - COH

17-Aug-2017	Appendix 4E

31-Jul-2017	Director Appointment/Resignation

26-Jul-2017	Change in substantial holding

13-Jul-2017	COCHLEAR TO EXPAND GLOBAL CAPACITY

5-Jul-2017	Ceasing to be a substantial holder

22-Jun-2017	Becoming a substantial holder

12-May-2017	Change in substantial holding

11-May-2017	Cochlear acquires audiology practice management software

4-May-2017	Cochlear Investor Day Presentations - Corrections

4-May-2017	COH Hosts Investor Day 4 May 2017

1-May-2017	Change in substantial holding

6-Apr-2017	COH Half Year Report F17

20-Feb-2017	Ceasing to be a substantial holder

14-Feb-2017	COH Half Year Results Analyst Presentation

14-Feb-2017	COH Half Year Results Media Release

14-Feb-2017	Dividend/Distribution - COH

14-Feb-2017	Half Yearly Report and Accounts

13-Feb-2017	COH RESIGNATION & APPOINTMENT OF COMPANY SECRETARY

10-Feb-2017	COH Announcement of New CFO

25-Jan-2017	Becoming a substantial holder

23-Dec-2016	Appendix 3B

16-Dec-2016	Appendix 3X

13-Dec-2016	Appointment of Prof Bruce Robinson as non-executive Director

28-Nov-2016	Change in substantial holding

18-Nov-2016	Decision in US Patent Infringement Case

11-Nov-2016	Appendix 3B

9-Nov-2016	Change of Director's Interest Notice - Chris Smith

7-Nov-2016	Appendix 3B

3-Nov-2016	Appendix 3B

1-Nov-2016	Appendix 3B

21-Oct-2016	Appendix 3B

21-Oct-2016	Appendix 3B

18-Oct-2016	COH 2016 AGM - Results of Meeting

18-Oct-2016	2016 Cochlear AGM Presentation to Shareholders

18-Oct-2016	2016 Chairman's AGM Address to Shareholders

14-Oct-2016	Becoming a substantial holder

5-Oct-2016	Appendix 3B

29-Sep-2016	Retirement of Chief Financial Officer

14-Sep-2016	Voting Form

14-Sep-2016	Notice of Annual General Meeting

13-Sep-2016	Appendix 3Y - Chris Smith

13-Sep-2016	Appendix 3B

2-Sep-2016	Appendix 3B

31-Aug-2016	Appendix 3B

26-Aug-2016	Appendix 3B

19-Aug-2016	Appendix 3B

18-Aug-2016	Appendix 3Y - Chris Smith

15-Aug-2016	Appendix 3B

12-Aug-2016	Appendix 3B

9-Aug-2016	COH Investor Handbook

9-Aug-2016	Dividend/Distribution - COH

9-Aug-2016	COH 2016 Tax Contribution Report

9-Aug-2016	Appendix 4G

9-Aug-2016	COH 2016 Corporate Governance Statement

9-Aug-2016	COH 2016 Annual Report

9-Aug-2016	COH FY16 Result Presentation Slides

9-Aug-2016	COH FY16 Result Announcement

9-Aug-2016	Appendix 4E

28-Jul-2016	COH Senior Executive Appointments

13-May-2016	Becoming a substantial holder

28-Apr-2016	Cochlear Hosts Investor Day 28 April 2016

14-Apr-2016	Appendix 3B

1-Apr-2016	Appendix 3Y - Rick Holliday-Smith

31-Mar-2016	Half Year Report 2016

7-Mar-2016	Appendix 3B

1-Mar-2016	Appendix 3B

16-Feb-2016	Ceasing to be a substantial holder

16-Feb-2016	Change in substantial holding

11-Feb-2016	COH Half Year Results Analyst Presentation

11-Feb-2016	COH Half Year Results Media Release 11.02.2016

11-Feb-2016	Dividend/Distribution - COH

11-Feb-2016	Half Year Report & Accounts

20-Nov-2015	Appendix 3B

5-Nov-2015	Appendix 3Y - Chris Smith

28-Oct-2015	Appendix 3Y - Chris Smith

20-Oct-2015	COH 2015 AGM - Results of Meeting

20-Oct-2015	20/10/15 Cochlear AGM Presentation to Shareholders

20-Oct-2015	20/10/15 Chairman's AGM Address to Shareholders

9-Oct-2015	Appendix 3B - Cochlear Employee Share Plan

18-Sep-2015	Form - Questions from Shareholders

18-Sep-2015	Voting Form

18-Sep-2015	Invitation letter from Chairman - AGM

18-Sep-2015	Notice of Annual General Meeting

15-Sep-2015	Appendix 3Y - Chris Smith

8-Sep-2015	Appendix 3B

5-Sep-2015	Change in substantial holding

4-Sep-2015	Appendix 3X - Chris Smith

1-Sep-2015	Appendix 3Z - Chris Roberts

1-Sep-2015	Appendix 3B

31-Aug-2015	Appendix 3B

31-Aug-2015	CEO HANDOVER EFFECTIVE AND RELATED BOARD CHANGES

27-Aug-2015	Appendix 3Y - Chris Roberts

25-Aug-2015	Appendix 3B

24-Aug-2015	Appendix 3Y - Glen Boreham

21-Aug-2015	Appendix 3Y - Dr Chris Roberts

17-Aug-2015	Appendix 3Y - Rick Holliday-Smith

12-Aug-2015	Dividend/Distribution - COH

11-Aug-2015	Full Year Results Analyst Presentation

11-Aug-2015	Full Year Statutory Accounts and Annual Report

30-Jun-2015	Updated Trading Policy

26-May-2015	COH Chris Smith Announced as Incoming CEO of Cochlear

21-Apr-2015	Judgment in United States Patent Infringement Laws

1-Apr-2015	DECISION IN US PATENT INFRINGEMENT CASE

26-Mar-2015	Half Year Report 2015

13-Mar-2015	Ceasing to be a substantial holder

10-Mar-2015	Appendix 3Y - Alison Deans

6-Mar-2015	Appendix 3Y - Chris Roberts

10-Feb-2015	COH Half Year Results Analyst Presentation

10-Feb-2015	COH Half Year Results Media Release 10.02.2015

10-Feb-2015	Half Year Report & Accounts

9-Dec-2014	Director Appointment

9-Dec-2014	Director Appointment

14-Oct-2014	COH 2014 AGM - Results of Meeting

14-Oct-2014	Cochlear AGM Presentation to Shareholders

14-Oct-2014	Chairman's AGM Address to Shareholders

5-Aug-2014	COH Full Year Results Analyst Presentation 05.08.2014

5-Aug-2014	COH Full Year Results Media Release 05.08.14

5-Aug-2014	Preliminary Final Report and Full Year Statutory Accounts

2-Jun-2014	COCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROP

27-Mar-2014	Half Year Report 2014

21-Mar-2014	FDA approves Cochlear Nucleus Hybrid for sale in USA

11-Feb-2014	COH Half Year Results Analyst Presentaton

11-Feb-2014	COH Half Year Results Media Release

11-Feb-2014	Half Year Report & Accounts

24-Jan-2014	COH Jury Trial Verdict on USA Patent Infringement Case

11-Nov-2013	FDA Advisory panel votes favourably on Hybrid hearing device

15-Oct-2013	Cochlear 2013 AGM - Results of Meeting

15-Oct-2013	Cochlear AGM Presentation to Shareholders

15-Oct-2013	Chairman's AGM Address to Shareholders

6-Aug-2013	Full Year Results Analyst Presentation

6-Aug-2013	Cochlear F'13 Full Year Results

6-Aug-2013	Full Year Financial Statements 4E 30 June 2013

17-Jun-2013	UBS Australian Healthcare Conference 2013 Presentation

3-Jun-2013	Cochlear update on Nucleus 6 launch and trading conditions

12-Mar-2013	F'13 Half Year Report

5-Feb-2013	Half Year Results Analyst Presentation

5-Feb-2013	Cochlear F'13 Half Year Results

5-Feb-2013	Financial Statements

16-Oct-2012	Cochlear 2012 AGM - Results of Meeting

16-Oct-2012	Cochlear AGM Presentation to Shareholders

16-Oct-2012	Chairman's AGM Address to Shareholders

7-Aug-2012	Full Year Results Analyst Presentation

7-Aug-2012	Update on Nucleus CI500 series implant recall

7-Aug-2012	F'12 Full Year Results

7-Aug-2012	Financial Statements

30-Apr-2012	Cochlear to vigorously patent infringement complaint

13-Mar-2012	F'12 Half Yearly Report

7-Feb-2012	Half Year Results Analyst Presentation

7-Feb-2012	F'12 Half Yearly Results

7-Feb-2012	Financial Statements

20-Dec-2011	Update on Nucleus CI500 Series Implant Recall

18-Oct-2011	Cochlear 2011 AGM - Results of Voting

18-Oct-2011	Cochlear AGM Presentation to Shareholders

18-Oct-2011	Chairman`s AGM Address to Shareholders

26-Sep-2011	Letter to Shareholders

12-Sep-2011	Cochlear announces voluntary recall of Nucleus CI500 cochlear implant range

9-Aug-2011	Full Year Results Analyst Presentation

9-Aug-2011	F'11 Full Year Results

9-Aug-2011	Financial Statements

8-Feb-2011	Half Year Results Analyst Presentation

8-Feb-2011	F' 11 Half Yearly Results

8-Feb-2011	Half Year Report and Accounts

19-Oct-2010	Cochlear 2010 AGM - Results of Meeting

19-Oct-2010	Chairman`s AGM Address to Shareholders

19-Oct-2010	Cochlear AGM Presentation to Shareholders

10-Aug-2010	Full Year Results Analyst Presentation

10-Aug-2010	F'10 Full Year Results

10-Aug-2010	Financial Statements

2-Aug-2010	Cochlear announces appointment of Non-Executive Director

4-Jun-2010	Settlement Agreement with the DOJ and OIG

17-Mar-2010	Cochlear Ltd Announces Appointment of New Chairman

15-Mar-2010	F'10 Half Yearly Report

9-Feb-2010	Half Year Results Analyst Presentation

9-Feb-2010	F'10 Half Year Results

9-Feb-2010	Financial Statements

20-Oct-2009	Cochlear 2009 AGM Results of Voting

20-Oct-2009	Cochlear AGM Presentation to Shareholders

20-Oct-2009	Chairmans AGM Address to Shareholders

4-Sep-2009	FDA Approval for Nucleus 5 System

11-Aug-2009	Full Year Results Analyst Presentation

11-Aug-2009	F'09 Full Year Results

11-Aug-2009	Financial Statements

14-Jul-2009	Cochlear Market Update

4-Jun-2009	Cochlear completes debt refinancing

3-Jun-2009	Conclusion of agreements for new global headquarters

16-Mar-2009	F'09 Half Year Report

10-Feb-2009	Half Year Results Analyst Presentation

10-Feb-2009	F'09 Half Year Results

10-Feb-2009	Financial Statements

21-Oct-2008	Cochlear 2008 AGM Results of Meeting

21-Oct-2008	Chairmans AGM Address to Shareholders

21-Oct-2008	Cochlear AGM Presentation to Shareholders

16-Sep-2008	Proxy Form

16-Sep-2008	Chairman`s Letter to Shareholders

16-Sep-2008	Notice of Annual General Meeting

16-Sep-2008	Annual Report to shareholders - Financial

16-Sep-2008	Annual Report to shareholders - Editorial

12-Aug-2008	Full Year Results Analyst Presentation

12-Aug-2008	F'08 Full Year Results

12-Aug-2008	Financial Statements

17-Mar-2008	F'08 Half Yearly Report

22-Feb-2008	COH to Work with FDA to Resolve Issues in Warning Letter

12-Feb-2008	Half Year Analyst Presentation

12-Feb-2008	F'08 Half Yearly Report

12-Feb-2008	Financial Statements

21-Dec-2007	Cochlear to Vigorously Defend Patent Infringement Complaint

23-Oct-2007	Cochlear 2006 AGM Results of Meeting

23-Oct-2007	Cochlear's plans for new Sydney Global Headquarters

23-Oct-2007	Chairman's AGM Address to Shareholders

23-Oct-2007	Cochlear AGM Presentation to Shareholders

14-Aug-2007	Full Year Results Analyst Presentation

14-Aug-2007	Financial Statements

14-Aug-2007	F'07 Full Year Results

13-Feb-2007	F'07 Half Year Results Analyst Presentation

13-Feb-2007	F'07 Half Year Results

13-Feb-2007	Half Yearly Report & Half Year Accounts

19-Dec-2006	Cochlear acquires key supplier's operations

15-Dec-2006	Appointment of Director: Mr Andrew Denver

30-Oct-2006	Annual Report

25-Oct-2006	Cochlear 2006 AGM Results of Meeting

24-Oct-2006	AGM Presentation to Shareholders

24-Oct-2006	Chairman's Address to Shareholders

15-Aug-2006	Full Year Results Analyst Presentation

15-Aug-2006	F'06 Full Year Results

15-Aug-2006	Financial Statements

18-Jul-2006	Cochlear Board Changes

8-Jun-2006	Cochlear Limited Wins Gold in New York

5-May-2006	Cochlear announces approximately $270m order for China

10-Mar-2006	Cochlear Limited Response to Share Price Increase

14-Feb-2006	Half Yearly Results Analyst Presentation

14-Feb-2006	F'06 Half Year Results

14-Feb-2006	Financial statements